US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment
- Posted on August 14, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment
By Kunal Das and Puyaan Singh Aug 14 (Reuters) - The U.S. Food and Drug Administration has approved a radioactive agent from Lantheus Holdings for use in brain scans to help assess patients for Alzheimer's disease, the company said on Friday. The agent, branded as Tauklarify, is injected before a positron emission tomography, or PET, scan. It makes abnormal deposits of tau proteins linked to
